The global respiratory pathogen testing kits market is projected to expand from USD 4,083.1 million in 2023 to USD 7,136.8 ...

Respiratory Pathogen Testing Kits MarketThe global respiratory pathogen testing kits market is projected to grow from USD 4,083.1 million in 2023 to USD 7,136.8 million by 2033, at a CAGR of 5.7%. The ...

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...

As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

January was a brutal month. I started our new year with a viral infection that lingered for weeks. A trip to the doctor’s ...

The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...

The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

After a promising decline in the 6th week of 2025, the number of people seeking medical help for respiratory infections, ...